Robert Tardio

Robert Tardio is an experienced sales professional in the medical device industry, currently serving as the NYC Business Manager at CVRx since November 2021, overseeing the launch of the FDA PMA approved Baroreflex Activation Therapy for heart failure. Prior roles include Account Executive at Bardy Diagnostics, where Robert managed sales of the Carnation Ambulatory Monitor patch, and Cardiology Account Manager at Abiomed, leading a $14 million annual sales franchise across NYC. Robert has also held positions such as Northeast Area Sales Director at CardioFocus, Territory Sales Manager at St. Jude Medical, and Principal Sales Representative at Boston Scientific, contributing to significant revenue growth and account management throughout a diverse range of cardiac technologies. Robert began a career in sales with SmithKline and holds a degree from Boston College.